ASTELLAS Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for ASTELLAS, and what generic alternatives to ASTELLAS drugs are available?
ASTELLAS has thirty-five approved drugs.
There are thirteen US patents protecting ASTELLAS drugs. There is one tentative approval on ASTELLAS drugs.
There are two hundred and eighty-two patent family members on ASTELLAS drugs in thirty-seven countries and sixty-seven supplementary protection certificates in nineteen countries.
Summary for ASTELLAS
International Patents: | 282 |
US Patents: | 13 |
Tradenames: | 19 |
Ingredients: | 14 |
NDAs: | 35 |
Patent Litigation for ASTELLAS: | See patent lawsuits for ASTELLAS |
Drugs and US Patents for ASTELLAS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | XTANDI | enzalutamide | CAPSULE;ORAL | 203415-001 | Aug 31, 2012 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
Astellas | MYCAMINE | micafungin sodium | INJECTABLE;INTRAVENOUS | 021506-002 | Mar 16, 2005 | AP | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | ||||
Astellas | XTANDI | enzalutamide | TABLET;ORAL | 213674-001 | Aug 4, 2020 | RX | Yes | No | 9,126,941 | See Plans and Pricing | See Plans and Pricing | ||||
Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 050560-003 | Sep 15, 1983 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ASTELLAS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astellas | CRESEMBA | isavuconazonium sulfate | POWDER;INTRAVENOUS | 207501-001 | Mar 6, 2015 | 7,459,561 | See Plans and Pricing |
Astellas | MYCAMINE | micafungin sodium | INJECTABLE;INTRAVENOUS | 021506-003 | Jun 27, 2006 | 6,107,458 | See Plans and Pricing |
Astellas | CYCLOCORT | amcinonide | CREAM;TOPICAL | 018116-002 | Approved Prior to Jan 1, 1982 | 4,158,055 | See Plans and Pricing |
Astellas | ASTAGRAF XL | tacrolimus | CAPSULE, EXTENDED RELEASE;ORAL | 204096-003 | Jul 19, 2013 | 8,551,522 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ASTELLAS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 3 mg/mL, 20 mL and 30 mL vials | ➤ Subscribe | 2005-04-18 |
➤ Subscribe | Injection | 0.08 mg/mL, 5 mL vial | ➤ Subscribe | 2012-04-10 |
➤ Subscribe | Extended-release Capsules | 0.5 mg, 1 mg, and 5 mg | ➤ Subscribe | 2013-11-15 |
➤ Subscribe | For Injection | 50 mg/vial and 100 mg/vial | ➤ Subscribe | 2014-06-16 |
➤ Subscribe | Injection | 3 mg/mL, 20 mL and 30 mL vials | ➤ Subscribe | 2005-04-16 |
➤ Subscribe | Tablets | 5 mg and 10 mg | ➤ Subscribe | 2009-04-08 |
➤ Subscribe | Capsules | 40 mg | ➤ Subscribe | 2016-08-31 |
International Patents for ASTELLAS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2015117244 | See Plans and Pricing |
Singapore | 10201408699T | See Plans and Pricing |
Norway | 2017019 | See Plans and Pricing |
Japan | WO2010128659 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ASTELLAS Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1893196 | 2013/061 | Ireland | See Plans and Pricing | PRODUCT NAME: ENZALUTAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/846 20130625 |
2428508 | 2020/004 | Ireland | See Plans and Pricing | PRODUCT NAME: GILTERITINIB OR A SALT THEREOF; REGISTRATION NO/DATE: EU/1/19/1399 20191024 |
1893196 | SPC/GB13/079 | United Kingdom | See Plans and Pricing | PRODUCT NAME: ENZLUTAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/13/846 20130625 |
1280795 | 1690011-0 | Sweden | See Plans and Pricing | PRODUCT NAME: ISAVUCONAZOLE; REG. NO/DATE: EU/1/15/1036 20151016 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.